Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Exenatide

Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

AstraZeneca · Phase 3 · Status n/r · Enrollment 150

NCT03671733

ArmPopulationDoseWeeksEstimandWeight change
LiraglutideObesity or overweightn/r4n/rn/r
ExenatideObesity or overweightn/r4n/rn/r
Exenatide Microspheres for InjectionObesity or overweightn/r4n/rn/r